EspeRare Foundation: Clinical Trials

2 trials sponsored by EspeRare Foundation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Recruiting 1

Follow EspeRare Foundation: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia
ER004 - X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)
Phase 2RecruitingEspeRare Foundation202022-04-262025-04-30
Rimeporide in Patients With Duchenne Muscular Dystrophy
Rimeporide - Muscular Dystrophy, Duchenne
Phase 1CompletedEspeRare Foundation202016-03-012019-07-18

Conditions studied

Ectodermal Dysplasia 1, Anhidrotic (1)  ·  Muscular Dystrophy, Duchenne (1)

Interventions

N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine (1)

Countries

France (2)  ·  Italy (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Germany (1)  ·  United States (1)

Top investigators

Holm Schneider, MD (1)

NIH funding

2015 (1)